97
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma

, , , , &
Pages 1721-1722 | Received 29 Apr 2009, Accepted 03 Jul 2009, Published online: 08 Oct 2009

References

  • Roos C, Stenke L, Ohm L, et al. Clinical imatinib mesylate treatment induces early normalization of aberrant leukotrine C4 synthase expression and activity in chronic myeloid leukaemia. Br J Haematol 2008; 142: 992–995
  • Hilberg T, Deigner H P, Möller E, et al. Transcription in response to physical stress – clues to the molecular mechanisms of exercise-induced asthma. FASEB J 2005; 19: 1492–1494
  • Hilberg T. Etiology of exercise-induced asthma: physical stress-induced transcription. Allergy Asthma Rep 2007; 7: 27–32
  • Berlin A A, Lukacs N W. Treatment of cockroach allergen asthma model with imatinib attenuates airway responses. Am J Respir Crit Care Med 2005; 171: 35–39
  • Leis J F, Primack S L, Schubach S E, et al. Management of life-threatening pulmonary leukostasis with single agent imatinib mesylate during CML myeloid blast crisis. Haematologica 2004; 89: 102–103

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.